Multifunctional nanosized emulsions for theragnosis of life threatening diseases

Recently, convergence of diagnosis, drug delivery and real-time noninvasive therapeutic monitoring took place (within the big pharma company) that leads to creation of the word “theragnosis” for the implementation of these three distinct pursuits simultaneously. This chapter envisions the use of the multifunctional oil-in-water (o/w) nanosized emulsions (NE) that carries imaging agents, anticancer or lipid lowering or antiatherosclerotic drug molecules and homing devices together for simultaneous imaging/diagnosing and treatment of cancer and atherosclerosis. A complete outline is given on the formulation of drug-loaded NE together with active and passive targeting moieties for accessing the unreachable organs present inside the human body. In order to make a better nanosized drug targeting systems for reachable and unreachable organs/parts of the body and thus, permitting the target place-precised drug delivery and/or improved drug bioabsorption, the NE is classified into three generations based on the research conducted over the previous 20 years.

[1]  C. Gatsonis,et al.  Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. , 2007, Radiology.

[2]  S. Lamberts,et al.  The endocrinology of aging. , 1997, Science.

[3]  Sanjeev Banerjee,et al.  Pancreatic cancer: pathogenesis, prevention and treatment. , 2007, Toxicology and applied pharmacology.

[4]  A. Alivisatos Perspectives on the Physical Chemistry of Semiconductor Nanocrystals , 1996 .

[5]  Y K Song,et al.  Antibody mediated lung targeting of long-circulating emulsions. , 1996, PDA journal of pharmaceutical science and technology.

[6]  Joseph D. Andrade,et al.  Blood compatibility of polyethylene oxide surfaces , 1995 .

[7]  S. Caruthers,et al.  Minute dosages of ανβ3‐targeted fumagillin nanoparticles impair Vx‐2 tumor angiogenesis and development in rabbits , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  James H Thrall,et al.  Biomarkers in imaging: realizing radiology's future. , 2003, Radiology.

[9]  C. Porter,et al.  Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion. , 1996, Journal of pharmaceutical sciences.

[10]  Yu Zhang,et al.  CT/fluorescence dual-modal nanoemulsion platform for investigating atherosclerotic plaques. , 2013, Biomaterials.

[11]  L. Fass Imaging and cancer: A review , 2008, Molecular oncology.

[12]  T. Redgrave,et al.  Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drug-carriers with prolonged circulation time , 1996 .

[13]  S. Rafla,et al.  The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. , 2005, International journal of radiation oncology, biology, physics.

[14]  G. Griffiths,et al.  Conjugation of an Anti‐B‐cell Lymphoma Monoclonal Antibody, LL2, to Long‐circulating Drug‐carrier Lipid Emulsions , 1999, The Journal of pharmacy and pharmacology.

[15]  Claudia Calcagno,et al.  Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. , 2011, ACS nano.

[16]  R. Böger Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials , 2005, Vascular medicine.

[17]  I. Kwon,et al.  Stable paclitaxel formulations in oily contrast medium. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[18]  J. Morrisett The role of lipoprotein[a] in atherosclerosis , 2000, Current atherosclerosis reports.

[19]  G. Wagner,et al.  Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac troponin-T, myoglobin, and creatine kinase MB(mass) , 2000, European heart journal.

[20]  H. Saito,et al.  Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions , 1998, Lipids.

[21]  R. Alexander,et al.  Vascular biology: the past 50 years. , 2000, Circulation.

[22]  S. Heinävaara,et al.  Breast cancer mortality with varying invitational policies in organised mammography , 2008, British Journal of Cancer.

[23]  J Kurhanewicz,et al.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. , 2000, Neoplasia.

[24]  G. Bartsch,et al.  Real‐time elastography for detecting prostate cancer: preliminary experience , 2007, BJU international.

[25]  H. Sprecher The roles of anabolic and catabolic reactions in the synthesis and recycling of polyunsaturated fatty acids. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[26]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[27]  Y. Rojanasakul,et al.  Transport mechanisms of the cornea: characterization of barrier permselectivity , 1989 .

[28]  H. Ohshima,et al.  Physicochemical Characterization of Parenteral Lipid Emulsion: Influence of Cosurfactants on Flocculation and Coalescence , 1995, Pharmaceutical Research.

[29]  Jeroen J. Bax,et al.  Universal definition of myocardial infarction. , 2007 .

[30]  R. Böger Association of Asymmetric Dimethylarginine and Endothelial Dysfunction , 2003, Clinical chemistry and laboratory medicine.

[31]  Zhong-gao Gao,et al.  Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. , 2007, Journal of the National Cancer Institute.

[32]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[33]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[34]  Floyd Top ten considerations in the development of parenteral emulsions. , 1999, Pharmaceutical science & technology today.

[35]  Z. Bhujwalla,et al.  Detection of tumor response to chemotherapy by 1H nuclear magnetic resonance spectroscopy: effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma 1 tumors. , 1998, Cancer research.

[36]  Cyrill Burger,et al.  Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. , 2003, International journal of radiation oncology, biology, physics.

[37]  Tsuyoshi Shiina,et al.  The impact of real-time tissue elasticity imaging (elastography) on the detection of prostate cancer: clinicopathological analysis , 2007, International Journal of Clinical Oncology.

[38]  M. Hashida,et al.  Long circulating emulsion carrier systems for highly lipophilic drugs. , 1994, Biological & pharmaceutical bulletin.

[39]  E. Stoelben,et al.  Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[40]  Daniel S. Miller,et al.  Cancer incidence and mortality, 1973‐1995 , 1998 .

[41]  Hesson Chung,et al.  Gene Delivery to the Rat Liver Using Cationic Lipid Emulsion/DNA Complex: Comparison between Intra-arterial, Intraportal and Intravenous Administration , 2002, Korean journal of radiology.

[42]  L Junck,et al.  Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. , 2011, The Lancet. Oncology.

[43]  Simon Benita,et al.  The potential of lipid emulsion for ocular delivery of lipophilic drugs. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[44]  H. Paajanen Increasing Use of Mammography Improves the Outcome of Breast Cancer in Finland , 2006, The breast journal.

[45]  K. Wasan,et al.  A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[46]  A. Jaffe,et al.  Bedside Multimarker Testing for Risk Stratification in Chest Pain Units: The Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) Study , 2001 .

[47]  Kaitai Zhang,et al.  An Approach to Studying Lung Cancer-related Proteins in Human Blood*S , 2005, Molecular & Cellular Proteomics.

[48]  Amin F. Majdalawieh,et al.  Adipocyte Enhancer-binding Protein-1 Promotes Macrophage Inflammatory Responsiveness by Up-Regulating NF-κB via IκBα Negative Regulation , 2007 .

[49]  Riccardo Lencioni,et al.  Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.

[50]  M. Yoshioka,et al.  Identification of the principal transcriptional regulators for low-fat and high-fat meal responsive genes in small intestine , 2017, Nutrition & Metabolism.

[51]  T. Uematsu,et al.  Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value? , 2007, Breast Cancer Research and Treatment.

[52]  S. Benita,et al.  The design and evaluation of a novel targeted drug delivery system using cationic emulsion-antibody conjugates. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[53]  T. Brown,et al.  Biomarkers of atherosclerosis: Clinical applications , 2008 .

[54]  Daehong Kim,et al.  Bimodal Perfluorocarbon Nanoemulsions for Nasopharyngeal Carcinoma Targeting , 2013, Molecular Imaging and Biology.

[55]  Axel Hoos,et al.  Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria , 2009, Clinical Cancer Research.

[56]  D. Vanel,et al.  Role of imaging to choose treatment , 2005, Cancer imaging : the official publication of the International Cancer Imaging Society.

[57]  I. Narabayashi,et al.  Diffusion-weighed MR imaging of pancreatic carcinoma , 2007, Abdominal Imaging.

[58]  Ora Israel,et al.  Cancer Recurrence: Diagnostic Value and Impact on Patient Management , 2004 .

[59]  Alexander Hartov,et al.  Electromagnetic breast imaging: average tissue property values in women with negative clinical findings. , 2004, Radiology.

[60]  S. Ganta,et al.  Anti-angiogenic and anti-cancer evaluation of betulin nanoemulsion in chicken chorioallantoic membrane and skin carcinoma in Balb/c mice. , 2013, Journal of biomedical nanotechnology.

[61]  C. Bloomfield,et al.  Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  J. Folkman,et al.  The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.

[63]  D. Lane,et al.  Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes. , 1998, European heart journal.

[64]  Mizuki Ishida,et al.  Effect of Injection Volume on the Pharmacokinetics of Oil Particles and Incorporated Menatetrenone after Intravenous Injection as O/W Lipid Emulsions in Rats , 2001, Journal of drug targeting.

[65]  Philip S Low,et al.  In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry , 2007, Proceedings of the National Academy of Sciences.

[66]  L. Svaasand,et al.  Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. , 2000, Neoplasia.

[67]  I. Kwon,et al.  The effects of serum on the stability and the transfection activity of the cationic lipid emulsion with various oils. , 2003, International journal of pharmaceutics.

[68]  Claudio Napoli,et al.  Rethinking primary prevention of atherosclerosis-related diseases. , 2006, Circulation.

[69]  Jennifer J. Gibson,et al.  Electromagnetic breast imaging: results of a pilot study in women with abnormal mammograms. , 2007, Radiology.

[70]  T. Berl,et al.  Serum Cystatin C Predicts Progression of Subclinical Coronary Atherosclerosis in Individuals With Type 1 Diabetes , 2007, Diabetes.

[71]  J. Shea,et al.  Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[72]  N. Altorki,et al.  Current state of imaging for lung cancer staging. , 2004, Thoracic surgery clinics.

[73]  G. Koning,et al.  Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery. , 2007, Anti-cancer agents in medicinal chemistry.

[74]  P M Schlag,et al.  Frequency-domain techniques enhance optical mammography: initial clinical results. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[75]  Samuel A. Wickline,et al.  Perfluorocarbon Nanoemulsions for Quantitative Molecular Imaging and Targeted Therapeutics , 2009, Annals of Biomedical Engineering.

[76]  P. Calder Conference on ‘ Malnutrition matters ’ Symposium 4 : Hot topics in parenteral nutrition Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults , 2009 .

[77]  Daniel P Barboriak,et al.  Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. , 2006, Radiology.

[78]  R. Chandra Grace A. Goldsmith Award lecture. Trace element regulation of immunity and infection. , 1985, Journal of the American College of Nutrition.

[79]  P. Libby Changing concepts of atherogenesis , 2000, Journal of internal medicine.

[80]  S. Vinnicombe,et al.  Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer , 2008, British Journal of Cancer.

[81]  N. Miyanaga,et al.  Tissue elasticity imaging for diagnosis of prostate cancer: A preliminary report , 2005, International journal of urology : official journal of the Japanese Urological Association.

[82]  A. Luttun,et al.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 , 2002, Nature Medicine.

[83]  Igor L. Medintz,et al.  Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.

[84]  N K Jain,et al.  Pegnology: a review of PEG-ylated systems. , 2002, Die Pharmazie.

[85]  Z. Duan,et al.  Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells. , 2011, Molecular pharmaceutics.

[86]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[87]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[88]  H. Maeda,et al.  Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.

[89]  P. Libby,et al.  Molecular biology of atherosclerosis. , 1997, International journal of cardiology.

[90]  S. Davis,et al.  The effect of stabilising agents on the organ distribution of lipid emulsions , 1989 .

[91]  Shuming Nie,et al.  Quantum dots in biology and medicine , 2004 .

[92]  Amir Lerman,et al.  Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[93]  V. Vermooten Rupture of the urethra, a new diagnostic sign. , 1946, Journal of Urology.

[94]  M. Marberger,et al.  Comparison of two qualitative assays, the UBC rapid test and the BTA stat test, in the diagnosis of urothelial cell carcinoma of the bladder. , 2000, Urology.

[95]  P. Ridker C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. , 2007, Journal of the American College of Cardiology.

[96]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[97]  Haibo Zhou,et al.  Translational Studies of Phenotypic Probes for the Mononuclear Phagocyte System and Liposomal Pharmacology , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[98]  G. Nickenig,et al.  Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[99]  D. Lichtenberg,et al.  Lipid infusion with different triglyceride cores (long-chain vs medium-chain/long-chain triglycerides): effect on plasma lipids and bilirubin binding in premature infants. , 1991, JPEN. Journal of parenteral and enteral nutrition.

[100]  Masao Tanaka,et al.  [Urine diacetylspermine as a novel tumor marker for pancreatobiliary carcinomas]. , 2004, Rinsho byori. The Japanese journal of clinical pathology.

[101]  Pericles Pericleous,et al.  Quantum dots hold promise for early cancer imaging and detection , 2012, International journal of cancer.

[102]  Adrian Saftoiu,et al.  Endoscopic ultrasound elastography-- a new imaging technique for the visualization of tissue elasticity distribution. , 2006, Journal of gastrointestinal and liver diseases : JGLD.

[103]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[104]  Alexander M. Seifalian,et al.  Clinical Potential of Quantum Dots , 2008, Journal of biomedicine & biotechnology.

[105]  M. Hashida,et al.  Controlled biodistribution of highly lipophilic drugs with various parenteral formulations. , 1993, Journal of drug targeting.

[106]  K. Nakao,et al.  Biological characterization of human brain natriuretic peptide (BNP) and rat BNP: species-specific actions of BNP. , 1990, Biochemical and biophysical research communications.

[107]  J. Nourooz-Zadeh Key issues in F2-isoprostane analysis. , 2008, Biochemical Society transactions.

[108]  I. Kwon,et al.  A Cationic Lipid Emulsion/DNA Complex as a Physically Stable and Serum-Resistant Gene Delivery System , 2000, Pharmaceutical Research.

[109]  E. Vitetta,et al.  The development of monoclonal antibodies for the therapy of cancer. , 1998, Critical reviews in eukaryotic gene expression.

[110]  M. Tsuang,et al.  Shifting emphasis from pharmacogenomics to theragnostics , 2006, Nature Biotechnology.

[111]  Susan Halabi,et al.  Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[112]  S. Benita,et al.  Influence of Emulsion Droplet Surface Charge on Indomethacin Ocular Tissue Distribution , 2000, Pharmaceutical development and technology.

[113]  M. Gimbrone Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis. , 1995, The American journal of cardiology.

[114]  S. Anker,et al.  Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease. , 2012, International journal of cardiology.

[115]  J. Alpert,et al.  Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction , 2008 .

[116]  I. Kwon,et al.  Optimization of Lipid Composition in Cationic Emulsion as In Vitro and In Vivo Transfection Agents , 2004, Pharmaceutical Research.

[117]  Max Wintermark,et al.  Magnetic resonance-guided focused ultrasound surgery: Part 2: A review of current and future applications. , 2012, Neurosurgery.

[118]  B. Pogue,et al.  Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast. , 2001, Radiology.

[119]  J. M. Harris,et al.  Pegylation: a novel process for modifying pharmacokinetics. , 2001, Clinical pharmacokinetics.

[120]  A. Papavassiliou,et al.  Asymmetric dimethylarginine (ADMA): is really a biomarker for cardiovascular prognosis? , 2011, International journal of cardiology.

[121]  T. Sakaeda,et al.  Effect of Oxyethylene Moieties in Hydrogenated Castor Oil on the Pharmacokinetics of Menatetrenone Incorporated in O/W Lipid Emulsions Prepared with Hydrogenated Castor Oil and Soybean Oil in Rats , 2003, Journal of drug targeting.

[122]  K. Nakao,et al.  Isolation and sequence determination of human brain natriuretic peptide in human atrium , 1990, FEBS letters.

[123]  K. Hoshi,et al.  Inhibition of bronchoconstriction by aerosol of a lipid emulsion containing prostaglandin E1 , 1983, The Journal of pharmacy and pharmacology.

[124]  M. Päivänsalo,et al.  Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males , 2006, Journal of internal medicine.

[125]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[126]  Jin Xie,et al.  Nanoparticle-based theranostic agents. , 2010, Advanced drug delivery reviews.

[127]  Feng Liu,et al.  Long-Circulating Emulsions (Oil-in-Water) as Carriers for Lipophilic Drugs , 1995, Pharmaceutical Research.

[128]  W. Denny,et al.  Phosphatidylinositol 3-kinase Inhibitor (PIK75) Containing Surface Functionalized Nanoemulsion for Enhanced Drug Delivery, Cytotoxicity and Pro-apoptotic Activity in Ovarian Cancer Cells , 2012, Pharmaceutical Research.

[129]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[130]  A. Tibell,et al.  Dissolving intravenous cyclosporin A in a fat emulsion carrier prevents acute renal side effects in the rat , 1993, Transplant international : official journal of the European Society for Organ Transplantation.

[131]  E Ciambellotti,et al.  [Determination++ of CA 15-3 in the control of primary and metastatic breast carcinoma]. , 1993, Minerva medica.

[132]  T. Sakaeda,et al.  O/W lipid emulsions for parenteral drug delivery. II. Effect of composition on pharmacokinetics of incorporated drug. , 1995, Journal of drug targeting.

[133]  M. Redfield,et al.  Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure. , 2003, Mayo Clinic proceedings.

[134]  T. Saba Physiology and physiopathology of the reticuloendothelial system. , 1970, Archives of internal medicine.

[135]  Y. Nishihara,et al.  O/W lipid emulsions for parenteral drug delivery. I. Pharmacokinetics of the oil particles and incorporated sudan II. , 1994, Biological & pharmaceutical bulletin.

[136]  P. Scheffer,et al.  Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? , 2009, Clinical chemistry.

[137]  M. Matoba,et al.  Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient. , 2007, Radiology.

[138]  Y. Kaneda,et al.  Local Overexpression of Monocyte Chemoattractant Protein‐1 at Vessel Wall Induces Infiltration of Macrophages and Formation of Atherosclerotic Lesion: Synergism With Hypercholesterolemia , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[139]  L. Horrocks,et al.  Health benefits of docosahexaenoic acid (DHA) , 1999, Pharmacological Research.

[140]  M. Stampfer,et al.  A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. , 1995, JAMA.

[141]  T. Olivecrona,et al.  Medium-chain versus long-chain triacylglycerol emulsion hydrolysis by lipoprotein lipase and hepatic lipase: implications for the mechanisms of lipase action. , 1990, Biochemistry.

[142]  M. Knobel,et al.  Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer , 2002, Journal of endocrinological investigation.

[143]  Kevin Brindle,et al.  New approaches for imaging tumour responses to treatment , 2008, Nature Reviews Cancer.

[144]  K. Ahrar,et al.  Palliative interventions for pain in cancer patients. , 2007, Seminars in interventional radiology.

[145]  S. Nie,et al.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.

[146]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[147]  D. Bluemke,et al.  Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. , 2008, AJR. American journal of roentgenology.

[148]  T. Koch,et al.  Auswirkungen einer parenteralen Ernährung mit n-3-Fettsäuren auf das Therapieergebnis - Eine multizentrische Analyse bei 661 Patienten , 2005 .

[149]  A. Baszkin,et al.  Interactions of a non-ionic surfactant with mixed phospholipid—oleic acid monolayers. Studies under dynamic conditions , 1991 .

[150]  S. Davis,et al.  The influence of emulsifying agents on the phagocytosis of lipid emulsions by macrophages , 1985 .

[151]  Obaidur Rahman,et al.  [11C]Carbon monoxide, a versatile and useful precursor in labelling chemistry for PET‐ligand development , 2007 .

[152]  J. K. Kruijt,et al.  Selective liver targeting of antivirals by recombinant chylomicrons — a new therapeutic approach to hepatitis B , 1995, Nature Medicine.

[153]  S. Lin,et al.  In vitro release, pharmacokinetic and tissue distribution studies of doxorubicin hydrochloride (Adriamycin HCl) encapsulated in lipiodolized w/o emulsions and w/o/w multiple emulsions. , 1992, Die Pharmazie.

[154]  Hui Zhi,et al.  Comparison of Ultrasound Elastography, Mammography, and Sonography in the Diagnosis of Solid Breast Lesions , 2007, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[155]  W. Gibler,et al.  Early CK‐MB Elevations Predict Ischemic Events in Stable Chest Pain Patients , 1994, Academic Emergency Medicine.

[156]  J Nuyts,et al.  18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). , 2003, European journal of cancer.

[157]  Douglas A Christensen,et al.  Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. , 2008, Ultrasonics.

[158]  Yong-Min Huh,et al.  Nanomaterials for theranostics: recent advances and future challenges. , 2015, Chemical reviews.

[159]  K. Brindle,et al.  Assessing responses to cancer therapy using molecular imaging. , 2006, Biochimica et biophysica acta.

[160]  Gorka Bastarrika,et al.  Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. , 2007, Chest.

[161]  K. Parker,et al.  "Sonoelasticity" images derived from ultrasound signals in mechanically vibrated tissues. , 1990, Ultrasound in medicine & biology.

[162]  S. Benita,et al.  Positively charged submicron emulsions — a new type of colloidal drug carrier , 1993 .

[163]  M. Engelgau,et al.  Vascular endothelium summary statement II: Cardiovascular disease prevention and control. , 2007, Vascular pharmacology.

[164]  Wei-Tse Yang,et al.  Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. , 2002, Radiology.

[165]  Fahima Dilnawaz,et al.  Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. , 2009, Biomaterials.

[166]  H. Brøndsted,et al.  Fat Emulsions Based on Structured Lipids (1,3-specific triglycerides): An Investigation of the in Vivo Fate , 1996, Pharmaceutical Research.

[167]  S. Vroegop,et al.  Kinetics and thermodynamics of emulsion delivery of lipophilic antioxidants to cells in culture. , 1995, Chemistry and physics of lipids.

[168]  J. Morrow,et al.  F2-Isoprostanes as markers of oxidative stress in vivo: An overview , 2005, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[169]  Byung-Tae Kim,et al.  Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. , 2005, Radiology.

[170]  B. Khan,et al.  Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome. , 2009, The American journal of cardiology.

[171]  T. Kobayashi,et al.  Lipid emulsions of palmitoylrhizoxin: effects of composition on lipolysis and biodistribution. , 1996, Biopharmaceutics & drug disposition.

[172]  P. Couvreur,et al.  Submicron Cationic Emulsions as a New Delivery System for Oligonucleotides , 2004, Pharmaceutical Research.

[173]  Mukesh Verma,et al.  Cancer Biomarkers: Are We Ready for the Prime Time? , 2010, Cancers.

[174]  R. Schnabel,et al.  Up-and-coming markers: myeloperoxidase, a novel biomarker test for heart failure and acute coronary syndrome application? , 2008, Congestive heart failure.

[175]  Shant Kumar,et al.  Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer , 2000, International journal of cancer.

[176]  Counterion effects on transfection activity of cationic lipid emulsion , 2001 .

[177]  E. Halpern,et al.  Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. , 2007, Urology.

[178]  W. Koenig,et al.  Biomarkers of Atherosclerotic Plaque Instability and Rupture , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[179]  M. Hersberger,et al.  Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction: Locally Increased Interleukin-6 and Serum Amyloid A but Decreased C-Reactive Protein , 2005, Circulation.

[180]  A. Wretlind Complete intravenous nutrition , 1972 .

[181]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.

[182]  Hongyu Zhao,et al.  Serum protein markers for early detection of ovarian cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[183]  S. Markowitz Atherosclerosis, just another cancer? , 1997, The Journal of clinical investigation.

[184]  Kyung Soo Lee,et al.  T1 non-small cell lung cancer: imaging and histopathologic findings and their prognostic implications. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[185]  Hanna Grubek-Jaworska,et al.  [Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer]. , 2004, Polskie Archiwum Medycyny Wewnetrznej.

[186]  A. Wretlind Complete intravenous nutrition. Theoretical and experimental background. , 1972, Nutrition and metabolism.

[187]  J. Sunamoto,et al.  Polysaccharide-coated oil droplets in oil-in-water emulsions as targetable carriers for lipophilic drugs. , 1991, Journal of pharmaceutical sciences.

[188]  P M Schlag,et al.  Development of a time-domain optical mammograph and first in vivo applications. , 1999, Applied optics.

[189]  Cockshott Id Propofol ('Diprivan') pharmacokinetics and metabolism--an overview. , 1985 .

[190]  A. Mitra,et al.  Novel approaches to nasal delivery of peptides and proteins , 2002 .

[191]  O. Gofrit,et al.  Anti-HER2 cationic immunoemulsion as a potential targeted drug delivery system for the treatment of prostate cancer. , 2007, Cancer research.

[192]  B. Cheson,et al.  Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. , 2006, Blood.

[193]  P. Alivisatos The use of nanocrystals in biological detection , 2004, Nature Biotechnology.

[194]  S. De Masi,et al.  Screening for hepatocellular carcinoma. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[195]  R. J. Ross,et al.  Nuclear magnetic resonance imaging and evaluation of human breast tissue: preliminary clinical trials. , 1982, Radiology.

[196]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[197]  M. Bally,et al.  Polyethylene glycol modified phospholipids stabilize emulsions prepared from triacylglycerol. , 1994, Journal of pharmaceutical sciences.